Expression of SPANX proteins in normal prostatic tissue and in prostate cancer

European Journal of Histochemistry

Volumn 54, Issue 3, 2010, Pages 180-182

  Salemi, M ^a   Calogero, A E ^a   Zaccarello, G ^a,c   Castiglione, R ^a   Cosentino, A ^b   Catanuso, M ^a   Vicari, E ^a   Rappazzo, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Gravina Hospital   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Cancer; Immunohistochemistry; Prostate; SPANX gene

Indexed keywords

EID: 77957327442     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2010.e41     Document Type: Article

References (17)

1. Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004;4:519-27.
2. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20:175-79.
3. Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, et al. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region. Hum Genet 2005;117:307-16.
4. Salemi M, Calogero AE, Di Benedetto D, Cosentino A, Barone N, Rappezzo G, et al. Expression of SPANX proteins in human-ejaculated spermatozoa and sperm precursors. Int J Androl 2004;27:134-9.
5. Salemi M, Calogero AE, Castiglione R, Tricoli D, Asero P, Rosa R, et al. Expression of SpanX proteins in normal testes and in testicular germ cell tumours. Int J Androl 2006;29:368-73.
6. Stephan DA, Howell GR, Teslovich TM, Coffey AJ, Smith L, Bailey-Wilson JE, et al. Physical and transcript map of the hereditary prostate cancer region at xq27. Genomics 2002;79:41-50.
7. Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, et al. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res 2005;15:1477-86.
8. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, et al. Recent segmental duplications in the human genome. Science 2002;297:1003-7.
9. Kouprina N, Noskov VN, Solomon G, Otstot J, Isaacs W, Xu J, et al. Mutational analysis of SPANX genes in families with X-linked prostate cancer. Prostate 2007;67:820-28.
10. Westbrook VA, Diekman AB, Klotz KL, Khole VV, von Kap-Herr C, Golden WL, et al. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol Reprod 2000;63:469-81.
11. Salemi M, Calogero AE, Bosco P, Castiglione R, La Vignera S, Borgione E, et al. Expression of SpanX mRNA in testicular germ cell tumors. Hum Cell 2006;19:87-90.
12. Zendman AJ, Zschocke J, van Kraats AA, de Wit NJ, Kurpisz M, Weidle UH, et al. The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines. Gene 2003;309:125-33.
13. Almanzar G, Olkhanud PB, Bodogai M, Dell'Agnola C, Baatar D, Hewitt SM, et al. Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clin Cancer Res 2009;15:1954-63.
14. Wang Z, Zhang Y, Liu H, Salati E, Chirivainternati M, Lim SH. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood 2003;101:955-60.
15. Salemi M, Bosco P, Calì F, Calogero AE, Soma PF, Galia A, et al. SPANX-B and SPANX-C (Xq27 region)gene dosage analysis in Sicilian patients with melanoma. Melanoma Res 2008;18:295-9.
16. Salemi M, Calogero AE, Vicari E, Migliore E, Zaccarello G, Cosentino A, et al. A high percentage of skin melanoma cells expresses SPANX proteins. Am J Dermatopathol 2009;31:182-6.
17. Westbrook VA, Schoppee PD, Diekman AB, Klotz KL, Allietta M, Hogan KT, et al. Genomic organization, incidence, and localization of the SPAN-X family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 2004;10: 101-12.